KVLE yields 8.98% · JNJ yields 2.13%● Live data
📍 KVLE pulled ahead of the other in Year 1
Combined, KVLE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KVLE + JNJ for your $10,000?
KVLE is passively managed to provide exposure to US companies that have high dividend yields that rank well on Value Lines proprietary system for safety and timeliness. The Value Line Safety Ranking System measures risk based on price stability and financial strength, while the Timeliness Ranking System measures price performance over a period. From the ranked companies, stocks are narrowed down by selecting those with the best dividend and beta target. Companies with 25% of the highest dividend-yielding stocks and those with a beta target of between 0.8 to 1 are selected. Finally, each company is assigned a score based on their Safety and Timelines rank, which determines their weighting. This approach allows the fund to adapt to the market environment. The index is rebalanced monthly. Before September 29, 2023, the fund traded as KFA Value Line Dynamic Core Equity Index ETF and prior to January 4, 2024, its index was 3D/L Value Line Dynamic Core Equity Index.
Full KVLE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.